Blackstone and TPG have agreed to acquire medical diagnostics firm Hologic in a deal worth up to $18.3 billion, it said on Tuesday, marking one of the largest healthcare take-private transactions this ...

The market awaits Hologic's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter. It's important for new investors to ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Hologic (Nasdaq: HOLX) said this ...

Hologic HOLX is set to release first-quarter fiscal 2026 results on Jan. 29, after the closing bell. The Zacks Consensus ...

HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...

Across the recent three months, 11 analysts have shared their insights on Hologic (NASDAQ:HOLX), expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed ...

The latest update on Hologic centers on a very slight trim to the fair value estimate, from about US$76.50 to about US$76.42 per share. This keeps it closely aligned with the proposed acquisition ...

10 analysts have shared their evaluations of Hologic (NASDAQ:HOLX) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...

In the preceding three months, 4 analysts have released ratings for Hologic (NASDAQ:HOLX), presenting a wide array of perspectives from bullish to bearish. The table below provides a snapshot of their ...

The company’s technology ranges from a commercial 3D mammography system to testing for cervical cancer, sexually transmitted infections and respiratory illnesses. From the Boston Business Journal.